Delivery Order SPE2DB24D2011-SPE2DB25FBRCM
Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Droxidopa 200 mg capsules (90-count units) with a ceiling value of $146,485.30. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The performance location is established at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) at a ceiling value of $1,266.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Droxidopa 100 mg capsules (90-count) on April 30, 2025, with a ceiling value of $4,010.25 and an ultimate completion date of May 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Droxidopa is a neurological medication used primarily to treat symptomatic...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Droxidopa 100 mg capsules (90-count unit). This competitive award, valued at $14,943.40, is structured as a firm fixed price delivery order with a completion date of September 9, 2025. The contract was not designated as a set-aside and represents a procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $9,262.08 to AmerisourceBergen Drug Corp for the supply of Droxidopa 200 mg capsules (90-count units) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Droxidopa is a neurological medication used to treat orthostatic...
- The Defense Logistics Agency awarded a delivery order valued at $6,203.90 to AmerisourceBergen Drug Corp for the supply of Droxidopa 100 mg capsules (90-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's...
- This federal contract award, valued at $7,207.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of droxidopa 100 mg capsules, a medication used to treat certain neurological conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of 4,564,741,740 units of the pharmaceutical product Droxidopa 100 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for a ceiling value of $7,021.56. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation....
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of 4,561,422,629 units of droxidopa 100 mg capsules. The contract has a ceiling value of $6,346.45 and a period of performance through July 7, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DROXIDOPA 100 MG CAPSULE 90S. The contract has a firm fixed price, with a ceiling value of $1,336.75, and an ultimate completion date of July 10, 2025. This delivery order is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is a significant federal contractor, holding a $999,999,999.00 Indefinite...